등록된 논문 143건

※ 클릭시 해당 논문페이지로 이동합니다.

• KCSG GU18-18비뇨기암

  Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18.

  • 저널 ESMO Open. 2023 Jun 27;8(4):101588. doi: 10.1016/j.esmoop.2023.101588
  • 제1저자 김미소
  • 교신저자 김범석

• KCSG LY20-06림프종

  Treatment pattern of chronic lymphocytic leukemia/small lymphocytic lymphoma in Korea: a multicenter retrospective study (KCSG LY20-06).

  • 저널 Korean J Intern Med. 2023 Sep;38(5):747-757.
  • 제1저자 김정선
  • 교신저자 최정혜

• KCSG BR21-18유방암

  A Survey of Practice Patterns for Clinical Nodal Staging Prior to Neoadjuvant Chemotherapy in Breast Cancer

  • 저널 Oncologist. 2023 Dec 11;28(12):e1142-e1151.
  • 제1저자 이한별, 이경훈
  • 교신저자 신경환, 장지현

• KCSG RC20-09희귀암

  Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients: KCSG-RC20-06

  • 저널 Cancer Med. 2023 Jul;12(14):15159-15175.
  • 제1저자 손병석
  • 교신저자 손병석

• KCSG ST13-10위암

  A Phase 3 Randomized Clinical Trial to Compare Efficacy and Safety between Combination Therapy and Monotherapy in Elderly Patients with Advanced Gastric Cancer (KCSG ST13-10).

  • 저널 Cancer Res Treat. 2023 May 25.
  • 제1저자 이근욱
  • 교신저자 최인실

• KCSG ST18-20위암

  AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20)

  • 저널 Oncologist . 2023 Apr 10;oyad059. doi: 10.1093/oncolo/oyad059. Online ahead of print.
  • 제1저자 서경진, 류민희
  • 교신저자 이근욱

• KCSG UN18-05희귀암

  Imatinib in c-KIT-mutated metastatic solid tumors: A multicenter trial of Korean Cancer Study Group (UN18-05 Trial)

  • 저널 Journal of Cancer Research and Therapeutics. April 04, 2023
  • 제1저자 김혜련, 이수진
  • 교신저자 김승태

• KCSG HN13-01두경부식도암

  Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01)

  • 저널 Cancers (Basel). 2023 Jan 12;15(2):471.
  • 제1저자 이윤규, 강은주
  • 교신저자 김혜련, 김효정

• KCSG LU17-21폐암

  A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21)

  • 저널 J Thorac Oncol. 2023 Feb;18(2):223-231.
  • 제1저자 정현애, 김미소
  • 교신저자 안명주

• KCSG BR18-14유방암

  Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B)

  • 저널 Breast. 2022 Oct;65:172-178.
  • 제1저자 심성훈, 김정은
  • 교신저자 박인혜

12345